SCHEMBL486190

SCHEMBL486190

CCc1ccc(-c2cncc(CNC(=O)O)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.48
XDH P47989 1/20 0.47
SLC22A12 Q96S37 1/20 0.47
EGLN1 Q9GZT9 1/20 0.47
SCN2A Q99250 1/20 0.45
SCN10A Q9Y5Y9 1/20 0.45
POLB P06746 1/20 0.44
KDM1A O60341 2/20 0.43
AKR1C3 P42330 1/20 0.42
LMNA P02545 1/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
KCNH2 Q12809 1/20 0.41
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16579491 0.79 XDH (0.58) HDAC1XDHSLC22A12EGLN1SCN10A
SCHEMBL5932688 0.78 CYP1A2 (0.55) POLBLMNAHTTSMN1; SMN2PPID
SCHEMBL641553 0.74 CYP11B1 (0.60) HDAC1XDHSLC22A12KDM1ACCNC
SCHEMBL21077975 0.73 PIK3CA (0.53) HDAC1POLBKDM1ALMNAMAPT
SCHEMBL24801835 0.73 CYP2A6 (0.49) HDAC1XDHSLC22A12CCNCCDK8
SCHEMBL640338 0.72 CYP2C9 (0.59) HDAC1XDHCCNCCDK8MAPT
SCHEMBL2570995 0.72 LMNA (0.62) POLBLMNAHTT
SCHEMBL27175798 0.72 LMNA (0.48) LMNAMAPTHTTSMN1; SMN2
SCHEMBL30020918 0.72 LMNA (0.48) LMNAMAPTHTTSMN1; SMN2
SCHEMBL486192 0.71 SLC22A12 (0.44) XDHSLC22A12EGLN1RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411363-B1 SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS BAYER IP GMBH (DE) 2015-10-07 EP disclosed
EP-2411363-A1 SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS Bayer Pharma AG (DE) 2012-02-01 EP disclosed
WO-2010108608-A1 SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-30 WO disclosed